Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass

Simpson, H. J.; Gandy, S. J.; Houston, J. G.; Rajendra, N. S.; Davies, J. I.; Struthers, A. D.
January 2010
Heart;Jan2010, Vol. 96 Issue 2, p148
Academic Journal
Objective: Left ventricular hypertrophy (LVH) confers high cardiovascular risk. Regression of LVH reduces risk. Patients with blood pressure in the normal range and LVH are common. We investigated whether further reduction in blood pressure would further regress LVH. Methods: 51 subjects with blood pressure in the normal range and echocardiographic left ventricular hypertrophy were randomly assigned to active treatment (antihypertensive medication) or placebo in a ratio of 2:1. The aim was to maintain office systolic blood pressure at 10 mm Hg less than baseline in the active arm and at baseline level in the placebo arm. Cardiac magnetic resonance imaging was used to measure change in left ventricular mass index over 12 months. Results: 35 subjects completed the study (active 23: placebo 12). Average mean baseline office systolic blood pressure was 122 (SD 9) mm Hg in the active group and 124 (9) mm Hg in the placebo group (p=0.646). The mean baseline left ventricular mass index was 65.88 (11.87) g/m² in the active group and 59.16 (11.13) g/m² in the placebo group (p?=?0.114). The mean difference between baseline and end of study office systolic blood pressure was -9.33 (8.56) mm?Hg in the active group and -0.08 (9.27) mm Hg in the placebo group (p=0.007). The mean change in left ventricular mass index was -4.68 (7.31) g/m² in the active group and +1.97 (6.68) g/m² in the placebo group (p=0.014). Conclusions: Reduction in office systolic blood pressure, already in the normal range, of approximately 9 mm Hg, leads to a reduction in left ventricular mass. Further work is required to see if this also leads to a reduction in cardiovascular events.


Related Articles

  • Cardiovascular changes during chronic hypertensive states. Drozdz, Dorota; Kawecka-Jaszcz, Kalina // Pediatric Nephrology;Sep2014, Vol. 29 Issue 9, p1507 

    It is well established that elevated blood pressure constitutes a major risk factor for coronary heart disease, arrythmias, heart failure, cerebrovascular disease, peripheral artery disease and renal failure. Blood pressure level and the duration of arterial hypertension (HTN) impact target...

  • Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients. Ago, Rika; Nakashima, Ayumu; Naito, Takayuki; Doi, Shigehiro; Ochiai, Mariko; Hamaguchi, Naoki; Yokoyama, Yukio; Tanaka, Junko; Yorioka, Noriaki; Masaki, Takao; Kohno, Nobuoki // Clinical & Experimental Nephrology;Dec2012, Vol. 16 Issue 6, p921 

    Background: When diagnosing hypertension (HT) it is essential to determine not only the level of raised blood pressure (BP), but also how the condition relates to organ damage. The best time to measure BP for diagnosing HT in patients on hemodialysis (HD) remains unclear. Methods: A total of 100...

  • Risk factors for left ventricular hypertrophy: Role of Na+-Li+ countertransport. NEVES, PEDRO LEÃO; FAISCA, MARÍLIA; GOMES, VELOSO; CACODCAR, SANJIVA; BERNARDO, IDALÉCIO; ANUNCIADA, ANA I.; VIEGAS, EMIDIO; MARTINS, HÉLIO; DA SILVA, A. MARQUES // Kidney International Supplement;Jun1996, Issue 55, pS-160 

    Left ventricular hypertrophy (LVH) is associated with an increase in cardiovascular death in essential hypertension (EH). The factors involved in LVH are multiple and complex. We looked for risk factors of LVH in a group of 28 nonobese patients with EH (mean age = 45.3 years). We analyzed the...

  • Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients. Milan, A.; Caserta, M. A.; Dematteis, A.; Naso, D.; Pertusio, A.; Magnino, C.; Puglisi, E.; Rabbia, F.; Pandian, N. G.; Mulatero, P.; Veglio, F. // Journal of Human Hypertension;Nov2009, Vol. 23 Issue 11, p743 

    Arterial hypertension is associated with an increased risk of atrial fibrillation (AF), and leads to a pronounced increase in morbidity and mortality. Left atrial volume (LAV) is an important prognostic marker in the older populations. The aim of our study was to identify the clinical and...

  • Left Ventricular Hypertrophy by Electrocardiogram. Kannel, William B.; Gordon, Tavla; Offutt, Dorsey // Annals of Internal Medicine;Jul69, Vol. 71 Issue 1, p89 

    Presents a study which examined the prevalence, incidence and mortality of left ventricular hypertrophy. Information on the disease; Methodology of the study; Results and discussion.

  • Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis. Satoh, Shinji; Omura, Soichiro; Inoue, Hiroko; Ejima, Emiko; Shimozono, Koutatsu; Hayashi, Makiko; Mori, Takahiro; Takenaka, Katsuhiko; Kawamura, Natsumi; Numaguchi, Kotaro; Mori, Etsuo; Asoh, Akemi; Nakamura, Toshihiro; Hiyamuta, Koji // Heart & Vessels;Sep2014, Vol. 29 Issue 5, p659 

    We investigated gender differences in factors influencing the electrocardiographic (ECG) findings of left ventricular hypertrophy (LVH) in patients with severe aortic stenosis (AS). The functional and geometric responses of the left ventricle to chronic pressure overload, such as hypertension...

  • Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial. Fuchs, Flávio D.; Fuchs, Sandra C.; Moreira, Leila B.; Gus, Miguel; Nóbrega, Antônio C.; Poli-de-Figueiredo, Carlos E.; Mion, Décio; Bortoloto, Luiz; Consolim-Colombo, Fernanda; Nobre, Fernando; Coelho, Eduardo Barbosa; Vilela-Martin, José F.; Moreno, Jr., Heitor; Cesarino, Evandro José; Franco, Roberto; Brandão, Andréa Araujo; de Sousa, Marcos R.; Ribeiro, Antônio Luiz Pinho; Jardim, Paulo Cesar; Neto, Abrahão Afiune // Trials;2011, Vol. 12 Issue 1, p65 

    Background: Blood pressure (BP) within pre-hypertensive levels confers higher cardiovascular risk and is an intermediate stage for full hypertension, which develops in an annual rate of 7 out of 100 individuals with 40 to 50 years of age. Non-drug interventions to prevent hypertension have had...

  • Effect of Green Coffee Bean Extract Consumption on Blood Pressure and Anthropometric Measures in Healthy Volunteers: A Pilot Crossover Placebo Controlled Study. AS. Al-Dujaili, Emad; N. Abuhajleh, Maha; Al-Turk, Walid // Jordan Journal of Pharmaceutical Sciences;2016, Vol. 9 Issue 3, p181 

    Background : Stress is known to contribute to obesity and hypertension and both are considered to be primary risk factors for cardiovascular disease. Green coffee bean extract (GCBE) contains chlorogenic acid (CGA) which is attributed with several health...

  • Evaluating and Managing Heart Failure with LVH. Nuovo, Jim // American Family Physician;01/15/2001, Vol. 63 Issue 2, p345 

    Presents an abstract of the study `Left Ventricular Hyperthropy. Pathogenesis, Detection and Prognosis,' by B.H. Lorell and B.A. Carabello, from the July 25, 2000 issue of `Circulation.'

  • Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone. Ori, Yaacov; Chagnac, Avry; Korzets, Asher; Zingerman, Boris; Herman-Edelstein, Michal; Bergman, Michael; Gafter, Uzi; Salman, Hertzel // Nephrology Dialysis Transplantation;Jul2013, Vol. 28 Issue 7, p1787 

    In a world with an elevated salt intake, we may need to redefine both normal aldosterone levels and what in fact constitutes primary aldosteronismBackground The incidence of left ventricular hypertrophy (LVH) in primary aldosteronism (PA) is higher than in essential hypertension. LVH is an...


Read the Article


Sign out of this library

Other Topics